[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 36, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 175560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & Senior Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 57, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.77, "open": 33.32, "dayLow": 31.98, "dayHigh": 34.34, "regularMarketPreviousClose": 33.77, "regularMarketOpen": 33.32, "regularMarketDayLow": 31.98, "regularMarketDayHigh": 34.34, "payoutRatio": 0.0, "beta": 0.225, "volume": 43063, "regularMarketVolume": 43063, "averageVolume": 40816, "averageVolume10days": 48390, "averageDailyVolume10Day": 48390, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 238209376, "fiftyTwoWeekLow": 0.94, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 28.0836, "twoHundredDayAverage": 34.793175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 182696000, "forwardPE": -5.1000915, "profitMargins": 0.0, "floatShares": 2983319, "sharesOutstanding": 7083240, "sharesShort": 169044, "sharesShortPriorMonth": 86404, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0239, "heldPercentInsiders": 0.22549, "heldPercentInstitutions": 0.7481, "shortRatio": 2.74, "shortPercentOfFloat": 0.035, "impliedSharesOutstanding": 7108720, "bookValue": 7.87, "priceToBook": 4.2731895, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -3444313, "trailingEps": -0.4, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 30.081331, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 33.63, "targetHighPrice": 94.12405, "targetLowPrice": 94.12405, "targetMeanPrice": 94.12405, "targetMedianPrice": 94.12405, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 55679916, "totalCashPerShare": 7.861, "totalDebt": 166596, "quickRatio": 87.643, "currentRatio": 88.273, "debtToEquity": 0.299, "returnOnAssets": -0.10569, "returnOnEquity": -0.11214, "freeCashflow": -2396884, "operatingCashflow": -4142686, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754089945, "regularMarketTime": 1754078401, "exchange": "NCM", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.414567, "regularMarketPrice": 33.63, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "postMarketChangePercent": -4.78739, "postMarketPrice": 32.02, "postMarketChange": -1.61, "regularMarketChange": -0.139999, "regularMarketDayRange": "31.98 - 34.34", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 40816, "fiftyTwoWeekLowChange": 32.690002, "fiftyTwoWeekLowChangePercent": 34.7766, "fiftyTwoWeekRange": "0.94 - 79.02", "fiftyTwoWeekHighChange": -45.389996, "fiftyTwoWeekHighChangePercent": -0.5744115, "fiftyTwoWeekChangePercent": 3008.133, "epsTrailingTwelveMonths": -0.4, "epsCurrentYear": -2.53, "priceEpsCurrentYear": -13.292491, "fiftyDayAverageChange": 5.546402, "fiftyDayAverageChangePercent": 0.19749613, "twoHundredDayAverageChange": -1.1631737, "twoHundredDayAverageChangePercent": -0.033431087, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "shortName": "Bright Minds Biosciences Inc.", "longName": "Bright Minds Biosciences Inc.", "marketState": "CLOSED", "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]